Oncogenic retinoic acid receptor γ knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/β-catenin pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65:5-29; PMID:25559415; http://dx.doi.org/10.3322/caac.21254
   PubMed Web of Science ®Google Scholar
• Davies JM, Goldberg RM. Treatment of metastatic colorectal cancer. Semin Oncol 2011; 38:552-60; PMID:21810514; http://dx.doi.org/10.1053/j.seminoncol.2011.05.009
   PubMed Web of Science ®Google Scholar
• Dai Y, Wilson G, Huang B, Peng M, Teng G, Zhang D, Zhang R, Ebert MP, Chen J, Wong BC, et al. Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer. Cell Death Dis 2014; 5:e1170; PMID:24722295; http://dx.doi.org/10.1038/cddis.2014.137
   PubMed Web of Science ®Google Scholar
• Gronemeyer H, Gustafsson J-Å, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 2004; 3:950-64; PMID:15520817; http://dx.doi.org/10.1038/nrd1551
   PubMed Web of Science ®Google Scholar
• Purton LE, Dworkin S, Olsen GH, Walkley CR, Fabb SA, Collins SJ, Chambon P. RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J Exp Med 2006; 203:1283-93; PMID:16682494; http://dx.doi.org/10.1084/jem.20052105
   PubMed Web of Science ®Google Scholar
• Yasuhara R, Yuasa T, Williams JA, Byers SW, Shah S, Pacifici M, Iwamoto M, Enomoto-Iwamoto M. Wnt/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover. J Biol Chem 2010; 285:317-27; PMID:19858186; http://dx.doi.org/10.1074/jbc.M109.053926
   PubMed Web of Science ®Google Scholar
• Goranov BB, Campbell Hewson QD, Pearson AD, Redfern CP. Overexpression of RARgamma increases death of SH-SY5Y neuroblastoma cells in response to retinoic acid but not fenretinide. Cell Death Differ 2006; 13:676-9; PMID:16341128; http://dx.doi.org/10.1038/sj.cdd.4401824
   PubMed Web of Science ®Google Scholar
• Pettersson F, Dalgleish AG, Bissonnette RP, Colston KW. Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. Br J Cancer 2002; 87:555-61; PMID:12189556; http://dx.doi.org/10.1038/sj.bjc.6600496
   PubMed Web of Science ®Google Scholar
• Yan TD, Wu H, Zhang HP, Lu N, Ye P, Yu FH, Zhou H, Li WG, Cao X, Lin YY, et al. Oncogenic potential of retinoic acid receptor-gamma in hepatocellular carcinoma. Cancer Res 2010; 70:2285-95; PMID:20197465; http://dx.doi.org/10.1158/0008-5472.CAN-09-2968
   PubMed Web of Science ®Google Scholar
• Kumar A, Kaur J, Chattopadhyay TK, Mathur M, Ralhan R. Differential expression of retinoic acid receptors in normal and malignant esophageal tissues. J Exp Ther Oncol 2004; 4:1-8; PMID:15255287
   PubMedGoogle Scholar
• Huang GL, Luo Q, Rui G, Zhang W, Zhang QY, Chen QX, Shen DY. Oncogenic activity of retinoic acid receptor gamma is exhibited through activation of the Akt/NF-kappaB and Wnt/beta-catenin pathways in cholangiocarcinoma. Mol Cell Biol 2013; 33:3416-25; PMID:23798555; http://dx.doi.org/10.1128/MCB.00384-13
   PubMed Web of Science ®Google Scholar
• Zhu H, Liu Z, Tang L, Liu J, Zhou M, Xie F, Wang Z, Wang Y, Shen S, Hu L, et al. Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells. Eur J Pharmacol 2012; 696:43-53; PMID:23051672; http://dx.doi.org/10.1016/j.ejphar.2012.09.046
   PubMed Web of Science ®Google Scholar
• Rocchi E, Khodjakov A, Volk EL, Yang CH, Litman T, Bates SE, Schneider E. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem Biophys Res Commun 2000; 271:42-6; PMID:10777678; http://dx.doi.org/10.1006/bbrc.2000.2590
   PubMed Web of Science ®Google Scholar
• Kimura Y, Morita SY, Matsuo M, Ueda K. Mechanism of multidrug recognition by MDR1/ABCB1. Cancer Sci 2007; 98:1303-10; PMID:17608770; http://dx.doi.org/10.1111/j.1349-7006.2007.00538.x
   PubMed Web of Science ®Google Scholar
• Sharom FJ. ABC multidrug transporters: Structure, function and role in chemoresistance. Pharmacogenomics 2008; 9:105-27; PMID:18154452; http://dx.doi.org/10.2217/14622416.9.1.105
   PubMed Web of Science ®Google Scholar
• Balcerczak E, Panczyk M, Piaskowski S, Pasz-Walczak G, Salagacka A, Mirowski M. ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer. Int J Colorectal Dis 2010; 25:1167-76; PMID:20533057; http://dx.doi.org/10.1007/s00384-010-0961-2
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang X, Wu X, Li W, Su P, Cheng H, Xiang L, Gao P, Zhou G. Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/beta-catenin pathway. Cancer Lett 2012; 323:106-13; PMID:22484497; http://dx.doi.org/10.1016/j.canlet.2012.03.039
   PubMed Web of Science ®Google Scholar
• Hu T, To KK, Wang L, Zhang L, Lu L, Shen J, Chan RL, Li M, Yeung JH, Cho CH. Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. Phytomedicine 2014; 21:1264-72; PMID:25172788; http://dx.doi.org/10.1016/j.phymed.2014.06.013
   PubMed Web of Science ®Google Scholar
• Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003; 33:401-6; PMID:12590264; http://dx.doi.org/10.1038/ng1117
   PubMed Web of Science ®Google Scholar
• Huang GL, Zhang W, Ren HY, Shen XY, Chen QX, Shen DY. Retinoid X receptor alpha enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/beta-catenin and nuclear factor-kappaB pathways. Cancer Sci 2015; 106:1515-23; PMID:26310932; http://dx.doi.org/10.1111/cas.12802
   PubMed Web of Science ®Google Scholar
• Huang GL, Shen DY, Cai CF, Zhang QY, Ren HY, Chen QX. Beta-escin reverses multidrug resistance through inhibition of the GSK3beta/beta-catenin pathway in cholangiocarcinoma. World J Gastroenterol 2015; 21:1148-57; PMID:25632187; http://dx.doi.org/10.3748/wjg.v21.i4.1148
   PubMed Web of Science ®Google Scholar
• Han YH, Zhou H, Kim JH, Yan TD, Lee KH, Wu H, Lin F, Lu N, Liu J, Zeng JZ, et al. A unique cytoplasmic localization of retinoic acid receptor-gamma and its regulations. J Biol Chem 2009; 284:18503-14; PMID:19416983; http://dx.doi.org/10.1074/jbc.M109.007708
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Ng L, Wan T, Chow A, Iyer D, Man J, Chen G, Yau TC, Lo O, Foo CC, Poon JT, et al. Osteopontin overexpression induced tumor progression and chemoresistance to oxaliplatin through induction of stem-like properties in human colorectal cancer. Stem Cells Int 2015; 2015:247892; PMID:26106421; http://dx.doi.org/10.1155/2015/247892
   PubMed Web of Science ®Google Scholar
• Kim KJ, Moon SM, Kim SA, Kang KW, Yoon JH, Ahn SG. Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells. Oncogene 2013; 32:3339-49; PMID:22907429; http://dx.doi.org/10.1038/onc.2012.354
   PubMed Web of Science ®Google Scholar
• Ozben T. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett 2006; 580:2903-9; PMID:16497299; http://dx.doi.org/10.1016/j.febslet.2006.02.020
   PubMed Web of Science ®Google Scholar
• Mochida Y, Taguchi K, Taniguchi S, Tsuneyoshi M, Kuwano H, Tsuzuki T, Kuwano M, Wada M. The role of P-glycoprotein in intestinal tumorigenesis: Disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice. Carcinogenesis 2003; 24:1219-24; PMID:12807720; http://dx.doi.org/10.1093/carcin/bgg073
   PubMed Web of Science ®Google Scholar
• Yasunaga M, Matsumura Y. Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer. Sci Rep 2014; 4:4852; PMID:24781822; http://dx.doi.org/10.1038/srep04852
   PubMed Web of Science ®Google Scholar
• Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20:781-810; PMID:15473860; http://dx.doi.org/10.1146/annurev.cellbio.20.010403.113126
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487:330-7; PMID:22810696; http://dx.doi.org/10.1038/nature11252
   PubMed Web of Science ®Google Scholar
• Voloshanenko O, Erdmann G, Dubash TD, Augustin I, Metzig M, Moffa G, Hundsrucker C, Kerr G, Sandmann T, Anchang B, et al. Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells. Nat Commun 2013; 4:2610; PMID:24162018; http://dx.doi.org/10.1038/ncomms3610
   PubMed Web of Science ®Google Scholar